Key result
Quantitative H-FABP assays demonstrated 81% sensitivity and 80% specificity for early myocardial infarction, but estimates were subject to substantial uncertainty and heterogeneity.
Why the study?
Does H-FABP testing at presentation improve early diagnostic sensitivity and specificity for myocardial infarction in patients with suspected acute coronary syndrome?
Meta-Analysis
Does H-FABP testing at presentation improve early diagnostic sensitivity and specificity for myocardial infarction in patients with suspected acute coronary syndrome?
H-FABP has modest diagnostic accuracy for early MI and may increase sensitivity when added to standard troponin, though at the cost of reduced specificity.
Answers are grounded in this paper and cite their sources.
Substantial uncertainty and heterogeneity limit H-FABP's role in early MI diagnosis; leaves open additive value to troponin.
BACKGROUND: Heart-type fatty acid binding protein (H-FABP) has been proposed as an early biomarker of myocardial infarction (MI). The authors aimed to undertake a systematic review and meta-analysis to estimate the early sensitivity and specificity of quantitative and qualitative H-FABP assays. METHODS: The authors undertook a systematic search using electronic databases, citation lists and expert contacts to identify all diagnostic cohort studies of patients presenting with suspected acute coronary syndrome that compared H-FABP at presentation to a reference standard based on the Universal definition of MI. Study quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies tool. Meta-analysis was conducted using Bayesian Markov chain Monte Carlo simulation. RESULTS: The authors included eight studies of quantitative H-FABP and nine studies of qualitative H-FABP. The summary estimates of sensitivity and specificity were 81% (95% prediction interval 50% to 95%) and 80% (26% to 98%) respectively for the quantitative assays and 68% (11% to 97%) and 92% (20% to 100%) respectively for the qualitative assays. Four studies reported the sensitivity of troponin and H-FABP at presentation in which the combination was considered positive if either test was positive. The addition of H-FABP to troponin increased sensitivity from 42-75% to 76-97% but decreased specificity from 94-100% to 65-93%. CONCLUSION: H-FABP has modest sensitivity and specificity for MI at presentation but estimates are subject to substantial uncertainty and primary data are subject to substantial heterogeneity. H-FABP may have a role alongside troponin in improving early sensitivity but comparison with high sensitivity troponin assays is required.
No takes yet. Share an insight, caveat, or question.
Carroll et al. (2012) conducted a meta-analysis in Suspected acute coronary syndrome. Heart-type fatty acid binding protein (H-FABP) assays vs. Reference standard based on the Universal definition of MI was evaluated on Early sensitivity and specificity for myocardial infarction (Sensitivity 81% and specificity 80% for quantitative assays). Quantitative H-FABP assays demonstrated 81% sensitivity and 80% specificity for early myocardial infarction, but estimates were subject to substantial uncertainty and heterogeneity.
Synapse has enriched 10 related papers. Consider them for comparative context: